ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
82,676.80
2.02%
S&P 500
5,521.52
-1.39%
Dow Jones
40,813.57
-1.30%
US Dollar vs Yen
148.9725
0.68%
Brent Oil
70.335
0.59%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Inozyme Pharma Inc (INZY) 銘柄情報

Inozyme Pharma Inc

Inozyme Pharma Inc (INZY)

NASDAQ
0.9997
-0.0803
(-7.44%)
終了 3月14日 5:00AM
15分遅延
0.9997
0.00
( 0.00% )
プレマーケット: 5:02PM
15分遅延

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.9997
買値
0.99
売値
1.01
出来高
50
0.00 日の範囲 0.00
0.98 52 週間の範囲 7.795
時価総額
64.221M
前日終値
0.9997
始値
-
時刻
50
@
1.01
最終取引時間
17:00:04
財務取引量
-
VWAP
-
平均取引量 (3 か月)
712,358
発行済株式数
64,240,198
配当利回り
-
PER
-0.90
1 株当たり利益 (EPS)
-1.11
歳入
-
純利益
-71.17M

Inozyme Pharma Inc について

Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 ... Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, or genetically engineered, fusion protein that is designed to correct a defect in the mineralization pathway caused by ENPP1 and ABCC6 deficiencies. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
www.inozyme.com
本社
Wilmington, Delaware, USA
設立
-
Inozyme Pharma Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker INZY. The last closing price for Inozyme Pharma was US$1. Over the last year, Inozyme Pharma shares have traded in a share price range of US$ 0.98 to US$ 7.795.

Inozyme Pharma currently has 64,240,198 shares in issue. The market capitalisation of Inozyme Pharma is US$64.22 million. Inozyme Pharma has a price to earnings ratio (PE ratio) of -0.90.

INZY 最新ニュース

その他のニュース

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
2025年3月11日
INZY (-7.44%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
2025年3月10日
INZY (-7.44%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年3月10日
INZY (-7.44%)

Form 8-K - Current report
Edgar (US Regulatory)
2025年1月10日
INZY (-7.44%)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
2024年12月10日
INZY (-7.44%)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.2503-20.0241.251.290.985929871.06440297CS
4-0.3703-27.02919708031.371.42840.985699861.18522282CS
12-1.7703-63.90974729242.773.180.987123581.61010007CS
26-5.0003-83.338333333366.240.985655512.45748751CS
52-4.7903-82.73402417965.797.7950.985056473.73831713CS
156-3.7403-78.90928270044.747.7950.985205263.98798259CS
260-16.9303-94.424428332417.9331.64990.983602004.85085231CS

INZY - Frequently Asked Questions (FAQ)

What is the current Inozyme Pharma share price?
The current share price of Inozyme Pharma is US$ 0.9997
How many Inozyme Pharma shares are in issue?
Inozyme Pharma has 64,240,198 shares in issue
What is the market cap of Inozyme Pharma?
The market capitalisation of Inozyme Pharma is USD 64.22M
What is the 1 year trading range for Inozyme Pharma share price?
Inozyme Pharma has traded in the range of US$ 0.98 to US$ 7.795 during the past year
What is the PE ratio of Inozyme Pharma?
The price to earnings ratio of Inozyme Pharma is -0.9
What is the reporting currency for Inozyme Pharma?
Inozyme Pharma reports financial results in USD
What is the latest annual profit for Inozyme Pharma?
The latest annual profit of Inozyme Pharma is USD -71.17M
What is the registered address of Inozyme Pharma?
The registered address for Inozyme Pharma is CORPORATION TRUST CENTER 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Inozyme Pharma website address?
The website address for Inozyme Pharma is www.inozyme.com
Which industry sector does Inozyme Pharma operate in?
Inozyme Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
RDUSRadius Recycling Inc
US$ 28.61
(109.44%)
30.41k
AAOIApplied Optoelectronics Inc
US$ 24.63
(55.20%)
325.98k
MRMMEDIROM Healthcare Technologies Inc
US$ 0.9058
(46.10%)
2.99M
BTOGBit Origin Ltd
US$ 0.3968
(45.40%)
24.77M
CLLSCellectis SA
US$ 1.82
(41.09%)
4.64M
TLFTandy Leather Factory Inc
US$ 2.01
(-32.55%)
1
CEADCEA Industries Inc
US$ 6.01
(-30.12%)
3
YMABY mAbs Therapeutics Inc
US$ 3.41
(-27.91%)
1
MKZRMackenzie Realty Capital Inc
US$ 1.55
(-22.11%)
2
ELVNEnliven Therapeutics Inc
US$ 16.20
(-20.16%)
243
BTOGBit Origin Ltd
US$ 0.3968
(45.40%)
24.77M
DGLYDigital Ally Inc
US$ 0.0917
(15.49%)
15.04M
ADTXAditxt Inc
US$ 0.0334
(0.00%)
6.29M
CLLSCellectis SA
US$ 1.82
(41.09%)
4.64M
SHViShares Short Treasury Bond ETF
US$ 110.28
(0.04%)
4.53M

INZY Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
INZY
Inozyme Pharma
TG
SVT1
Severn Trent
NASDAQ
ABMAXXX
Ubs Ag London Branch Aut...
AQSE
SPDI.GB
Secure Property Developm...
BOV
AESO3
AurenOperaxoes ON
BOV
SMAL11
IShares BMF Bovespa Smal...
ASX
IFXHD
Int Finance
NASDAQ
INSE
Inspired Entertainment
NYSE
CMCM
Cheetah Mobile
EU
USAC
Amundi ETF ICAV
NASDAQ
ABJYHXX
Morgan Stanley Bank Na P...
FX
NZBNZOIR
Reserve Bank of NZ Offic...
COIN
ICOSEUR
ASX
GSS
Genetic Signatures
BOV
CEED4
CEEE-D PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す